Successful treatment of MRSA native valve endocarditis with oral linezolid therapy: A case report

Journal of Infection

Volumn 51, Issue 4, 2005, Pages

  Nathani, N ^a   Iles, P ^b   Elliott, T S J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

Endocarditis; Linezolid; MRSA; Vancomycin

Indexed keywords

AMINOPHYLLINE; BRONCHODILATING AGENT; LINEZOLID; STEROID; TERBUTALINE; VANCOMYCIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; BONE MARROW SUPPRESSION; CASE REPORT; CHRONIC DISEASE; COMORBIDITY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DRUG TISSUE LEVEL; FEMALE; FEMORAL VEIN; HUMAN; INTRAVENOUS CATHETER; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PULMONARY VALVE DISEASE; STAPHYLOCOCCUS INFECTION; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE DISEASE; VASCULAR ACCESS;

ACETAMIDES; ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS; ASTHMA; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; METHICILLIN RESISTANCE; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 28044443181     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2005.02.016     Document Type: Article

References (13)

1. D.T. Durack P.B. Beeson Experimental bacterial endocarditis. II. Survival of bacteria in endocardial vegetations Br J Exp Pathol 53 1972 50
2. J.S. Li D.J. Sexton N. Mick R. Nettles V.G. Fowler Jr T. Ryan et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis Clin Infect Dis 30 2000 633-638
3. P.A. Heidenreich F.A. Masoudi B. Maini T.M. Chou E. Foster N.B. Schiller et al. Echocardiography in patients with suspected endocarditis: A cost-effective analysis Am J Med 107 1999 198-208
4. V.G. Fowler Jr J. Li G.R. Corey J. Boley K.A. Marr A.K. Gopal et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: Experience in 103 patients J Am Coll Cardiol 30 1997 1072-1078
5. C. Vuille M. Nidorf A.E. Weyman M.H. Picard Natural history of vegetations during successful medical treatment of endocarditis Am Heart J 128 6 Pt 1 1994 1200-1209
6. C.J. Henwood D.M. Livermore A.P. Johnson D. James M. Warner Gardiner A and the Linezolid Study Group Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid J Antimicrob Chemother 46 2000 931-940
7. C.F. Dailey L.C. Dileto-Fang L.V. Buchanan M.P. Oramas-shirey D.H. Batts C.W. Ford et al. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant staphylococcal aureus Antimicrob Agents Chemother 45 2001 2304-2308
8. L.D. Dresser M.J. Rybak The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials Pharmacotherapy 18 1998 456-462
9. Stalker DJ, Wajszczuk CP, Batts DH, Linezolid safety, tolerance, and pharmacokinetics after intravenous dosing twice daily for 7.5 days (abstract A116). In: Programs and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Ontario, Canada, September 28-October 1; 1997.
10. S.A. McNeil N.M. Clark P.H. Chandrasekar C.A. Kauffman Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/ dalfopristin) Clin Infect Dis 30 2000 403-404
11. M.E. Jones F.J. Schmitz A.C. Fluit J. Acar R. Gupta J. Verhoef et al. Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an international surveillance programme Eur J Clin Microbiol Infect Dis 18 1999 403-407
12. V. Ravindran J. John G.C. Kaye R.E. Meigh Successful use of oral linezolid as a single active agent in endocarditis unresponsive to conventional antibiotic therapy J Infect 47 2003 164-166
13. P. Viale C. Scolari P. Colombini F. Cristini B. Cadeo L. Pagani Sequential regimen for early post-surgical infective endocarditis due to methicillin-resistant staphylococcal aureus (MRSA), unresponsive to standard antibiotic therapy: A case report J Chemother 14 5 2002 526-529